Brokerages Set The Chemours Company (NYSE:CC) Target Price at $17.38

Key Points

• The Chemours Company has received a consensus recommendation of "Moderate Buy" from nine brokerages, with an average 1-year price target of $17.37.
• CEO Denise Dignam purchased 4,068 shares of Chemours at an average price of $12.06 per share, reflecting her confidence in the company's future.
• Chemours reported earnings of $0.58 EPS, surpassing expectations and indicating a revenue increase of 5.0% year-over-year.

The Chemours Company (NYSE:CC - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $17.3750.

CC has been the subject of a number of recent research reports. The Goldman Sachs Group cut their price objective on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Mizuho lifted their price target on shares of Chemours from $13.00 to $16.00 and gave the company an "outperform" rating in a research report on Tuesday, July 15th. Barclays reduced their price target on Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 28th. Royal Bank Of Canada raised their price objective on Chemours from $14.00 to $15.00 and gave the stock an "outperform" rating in a research note on Thursday, July 3rd. Finally, Wall Street Zen downgraded Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st.

Chemours Stock Performance

NYSE CC traded up $0.56 on Friday, reaching $15.65. The stock had a trading volume of 4,308,402 shares, compared to its average volume of 3,434,551. The company has a debt-to-equity ratio of 17.16, a current ratio of 1.68 and a quick ratio of 0.83. The company has a market cap of $2.34 billion, a P/E ratio of -5.59 and a beta of 1.61. The firm has a fifty day moving average of $13.73 and a two-hundred day moving average of $12.72. Chemours has a 1-year low of $9.13 and a 1-year high of $22.38.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.12. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the firm earned $0.38 earnings per share. The company's revenue was up 5.0% on a year-over-year basis. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts anticipate that Chemours will post 2.03 EPS for the current year.

Chemours Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 15th will be given a $0.0875 dividend. The ex-dividend date is Friday, August 15th. This represents a $0.35 annualized dividend and a dividend yield of 2.2%. Chemours's payout ratio is presently -12.50%.

Insider Buying and Selling at Chemours

In other news, CEO Denise Dignam purchased 4,068 shares of Chemours stock in a transaction that occurred on Friday, August 8th. The shares were acquired at an average price of $12.06 per share, for a total transaction of $49,060.08. Following the transaction, the chief executive officer owned 191,546 shares of the company's stock, valued at approximately $2,310,044.76. The trade was a 2.17% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.34% of the company's stock.

Institutional Investors Weigh In On Chemours

A number of large investors have recently modified their holdings of CC. Millennium Management LLC boosted its stake in shares of Chemours by 60.4% in the 1st quarter. Millennium Management LLC now owns 4,022,782 shares of the specialty chemicals company's stock valued at $54,428,000 after purchasing an additional 1,515,520 shares in the last quarter. Scopia Capital Management LP lifted its stake in Chemours by 71.7% in the 2nd quarter. Scopia Capital Management LP now owns 3,355,261 shares of the specialty chemicals company's stock valued at $38,418,000 after purchasing an additional 1,401,539 shares during the last quarter. Vanguard Group Inc. boosted its position in Chemours by 8.3% in the first quarter. Vanguard Group Inc. now owns 16,487,008 shares of the specialty chemicals company's stock valued at $223,069,000 after buying an additional 1,263,047 shares in the last quarter. State Street Corp grew its stake in shares of Chemours by 22.7% during the second quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company's stock worth $70,009,000 after buying an additional 1,131,682 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Chemours by 41.4% during the second quarter. Geode Capital Management LLC now owns 3,484,416 shares of the specialty chemicals company's stock worth $39,901,000 after buying an additional 1,020,933 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.